North American Pharma Supply Chain: Role of Superdisintegrants in ODTs 2027 Get Full Report: https://www.businessmarketinsights.com/reports/north-america-superdisintegrantsmarket North America, the superdisintegrants market, is anticipated to reach US$ 248.18 Mn in 2027 from US$ 136.37 Mn in 2019. The market is projected to grow with a CAGR of 7.9% from 2020-2027. Get a sample PDF of the report – https://www.businessmarketinsights.com/sample/TIPRE00009244?utm_source=Blog&utm_medium=10640 The region is witnessing exponential growth in the prevalence of chronic diseases. Factors such as the progression of viruses, bacteria, parasites, coupled with the growing adoption of a sedentary lifestyle, genetic conditions, and consumption of poor diet, are responsible for the increasing prevalence of these diseases. Also, oral drug delivery remains the most common route of drug administration in the healthcare world. Solid dosage forms typically include tablets, capsules, and powders for the treatment of particular disease conditions. Moreover, the growing emphasis on novel drug delivery approach is expected to boost awareness and focus on the utilization of orally disintegrating tablets during the forecast period. Superdisintegrants or orally disintegrating tablets are gaining traction due to advantages such as ease of drug administration and better compliance for pediatric and geriatric patients. #Superdisintegrants #OrallyDisintegratingTablets #PharmaceuticalExcipients #DrugDelivery #NorthAmericaPharma #ODTs #Crospovidone #CroscarmelloseSodium #GenericDrugs #TabletFormulation #PharmaInnovation #PatientCompliance #ExcipientMarket #PediatricDosing #GeriatricCare #NeurologicalDrugs